The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Jump to: Company in focus,
Offsprings
Parent entities and officers
5
- 1
Patel, Kalpesh Kanubhai
Born in December 1959Individual (14 offsprings)Officer2020-02-13 ~ nowOF - Director → CIF 0 - 2
Patel, Minesh Kanubhai
Director born in January 1956Individual (39 offsprings)Officer2020-02-14 ~ 2020-02-15OF - Director → CIF 0 - 3
Patel, Amar Shilan Kalpesh
Born in May 1991Individual (5 offsprings)Officer2020-02-13 ~ nowOF - Director → CIF 0 - 4
Patel, Nehul
Director born in March 1995Individual (3 offsprings)Officer2020-02-14 ~ 2020-02-15OF - Director → CIF 0 - 5
Patel, Chhaya Kalpesh
Managing Director born in May 1962Individual (4 offsprings)Officer2020-02-13 ~ 2020-02-15OF - Director → CIF 0
Company in focus
NOVUSPHARMA (UK) LTD
Period: 2020-02-13 ~ now
Company number: 12461049
Registered name
NOVUSPHARMA (UK) LTD - now
Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Cost of Sales
-10,035,928 GBP2024-07-01 ~ 2025-06-30
-9,381,471 GBP2023-07-01 ~ 2024-06-30
Administrative Expenses
-4,070,225 GBP2024-07-01 ~ 2025-06-30
-3,926,201 GBP2023-07-01 ~ 2024-06-30
Other Interest Receivable/Similar Income (Finance Income)
3,515 GBP2024-07-01 ~ 2025-06-30
6,226 GBP2023-07-01 ~ 2024-06-30
Profit/Loss on Ordinary Activities Before Tax
-278,927 GBP2024-07-01 ~ 2025-06-30
-38,273 GBP2023-07-01 ~ 2024-06-30
Profit/Loss
-320,437 GBP2024-07-01 ~ 2025-06-30
-140,811 GBP2023-07-01 ~ 2024-06-30
Intangible Assets
Goodwill
5,364,713 GBP2025-06-30
5,806,713 GBP2024-06-30
Property, Plant & Equipment
192,369 GBP2025-06-30
213,280 GBP2024-06-30
Fixed Assets
5,557,082 GBP2025-06-30
6,019,993 GBP2024-06-30
Debtors
1,356,089 GBP2025-06-30
1,248,082 GBP2024-06-30
Cash at bank and in hand
723,817 GBP2025-06-30
943,327 GBP2024-06-30
Current Assets
3,055,326 GBP2025-06-30
3,340,608 GBP2024-06-30
Creditors
Amounts falling due within one year
-6,627,206 GBP2025-06-30
-4,153,998 GBP2024-06-30
Net Current Assets/Liabilities
-3,571,880 GBP2025-06-30
-813,390 GBP2024-06-30
Total Assets Less Current Liabilities
1,985,202 GBP2025-06-30
5,206,603 GBP2024-06-30
Creditors
Amounts falling due after one year
-1,845,235 GBP2025-06-30
-4,739,214 GBP2024-06-30
Net Assets/Liabilities
102,227 GBP2025-06-30
422,664 GBP2024-06-30
Equity
Called up share capital
10,000 GBP2025-06-30
10,000 GBP2024-06-30
10,000 GBP2023-06-30
Retained earnings (accumulated losses)
92,227 GBP2025-06-30
412,664 GBP2024-06-30
553,475 GBP2023-06-30
Equity
102,227 GBP2025-06-30
422,664 GBP2024-06-30
Profit/Loss
Retained earnings (accumulated losses)
-320,437 GBP2024-07-01 ~ 2025-06-30
-140,811 GBP2023-07-01 ~ 2024-06-30
Audit Fees/Expenses
8,000 GBP2024-07-01 ~ 2025-06-30
8,000 GBP2023-07-01 ~ 2024-06-30
Average Number of Employees
902024-07-01 ~ 2025-06-30
802023-07-01 ~ 2024-06-30
Wages/Salaries
1,906,465 GBP2024-07-01 ~ 2025-06-30
1,732,241 GBP2023-07-01 ~ 2024-06-30
Pension & Other Post-employment Benefit Costs/Other Pension Costs
36,397 GBP2024-07-01 ~ 2025-06-30
30,581 GBP2023-07-01 ~ 2024-06-30
Staff Costs/Employee Benefits Expense
2,107,636 GBP2024-07-01 ~ 2025-06-30
1,901,018 GBP2023-07-01 ~ 2024-06-30
Director Remuneration
51,667 GBP2024-07-01 ~ 2025-06-30
82,667 GBP2023-07-01 ~ 2024-06-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-6,986 GBP2024-07-01 ~ 2025-06-30
6,433 GBP2023-07-01 ~ 2024-06-30
Intangible Assets - Gross Cost
Goodwill
6,859,039 GBP2024-06-30
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
1,494,326 GBP2025-06-30
1,052,326 GBP2024-06-30
Intangible Assets - Increase From Amortisation Charge for Year
Goodwill
442,000 GBP2024-07-01 ~ 2025-06-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
5,000 GBP2025-06-30
5,000 GBP2024-06-30
Furniture and fittings
339,251 GBP2025-06-30
320,903 GBP2024-06-30
Property, Plant & Equipment - Gross Cost
392,973 GBP2025-06-30
364,625 GBP2024-06-30
Land and buildings, Under hire purchased contracts or finance leases
48,722 GBP2025-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
3,597 GBP2025-06-30
3,129 GBP2024-06-30
Furniture and fittings
189,697 GBP2025-06-30
143,876 GBP2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
200,604 GBP2025-06-30
151,345 GBP2024-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
468 GBP2024-07-01 ~ 2025-06-30
Furniture and fittings
45,821 GBP2024-07-01 ~ 2025-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
49,259 GBP2024-07-01 ~ 2025-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
7,310 GBP2025-06-30
Property, Plant & Equipment
Plant and equipment
1,403 GBP2025-06-30
1,871 GBP2024-06-30
Furniture and fittings
149,554 GBP2025-06-30
177,027 GBP2024-06-30
Land and buildings
34,382 GBP2024-06-30
Finished Goods/Goods for Resale
975,420 GBP2025-06-30
1,149,199 GBP2024-06-30
Trade Debtors/Trade Receivables
Current
1,099,308 GBP2025-06-30
998,898 GBP2024-06-30
Other Debtors
Current
203,109 GBP2025-06-30
187,607 GBP2024-06-30
Prepayments/Accrued Income
Current
53,672 GBP2025-06-30
61,577 GBP2024-06-30
Bank Borrowings/Overdrafts
Current
2,988,856 GBP2025-06-30
181,959 GBP2024-06-30
Trade Creditors/Trade Payables
Current
3,139,740 GBP2025-06-30
3,512,328 GBP2024-06-30
Corporation Tax Payable
Current
48,475 GBP2025-06-30
138,358 GBP2024-06-30
Other Taxation & Social Security Payable
Current
47,145 GBP2025-06-30
37,510 GBP2024-06-30
Other Creditors
Current
368,259 GBP2025-06-30
256,002 GBP2024-06-30
Accrued Liabilities/Deferred Income
Current
34,731 GBP2025-06-30
27,841 GBP2024-06-30
Creditors
Current
6,627,206 GBP2025-06-30
4,153,998 GBP2024-06-30
Bank Borrowings/Overdrafts
Non-current
1,845,235 GBP2025-06-30
4,739,214 GBP2024-06-30
Bank Borrowings
4,834,091 GBP2025-06-30
4,921,173 GBP2024-06-30
Total Borrowings
Current
2,988,856 GBP2025-06-30
181,959 GBP2024-06-30
Non-current
1,845,235 GBP2025-06-30
4,739,214 GBP2024-06-30
Par Value of Share
Class 1 ordinary share
1 GBP2024-07-01 ~ 2025-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10,000 shares2025-06-30
10,000 shares2024-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
246,450 GBP2025-06-30
246,450 GBP2024-06-30
Between two and five year
782,332 GBP2025-06-30
852,235 GBP2024-06-30
More than five year
2,313,549 GBP2025-06-30
2,484,807 GBP2024-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
3,342,331 GBP2025-06-30
3,583,492 GBP2024-06-30
- Registered number 12461049
NOVUSPHARMA (UK) LTD
Info64 High Street, Pinner HA5 5QAPRIVATE LIMITED COMPANY incorporated on 2020-02-13 (6 years 3 months). The status of the company number is Active.The last date of confirmation statement was made at 2026-03-16CIF 0
Offspring entities and appointments
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 22 April 2026 and
licensed under the Open Government Licence v3.0.